These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6970896)

  • 1. IgG inhibitor of polymorphonuclear-leukocyte motility.
    Maderazo EG; Woronick CL
    N Engl J Med; 1981 Apr; 304(18):1109. PubMed ID: 6970896
    [No Abstract]   [Full Text] [Related]  

  • 2. Recognition of human polymorphonuclear leukocyte receptors for leukotriene B4 by rabbit anti-idiotypic antibodies to a mouse monoclonal antileukotriene B4.
    Gifford LA; Chernov-Rogan T; Harvey JP; Koo CH; Goldman DW; Goetzl EJ
    J Immunol; 1987 Feb; 138(4):1184-9. PubMed ID: 3027172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunoglobulin (IgG) inhibitor of polymorphonuclear leukocyte motility in a patient with recurrent infection.
    Kramer N; Perez HD; Goldstein IM
    N Engl J Med; 1980 Nov; 303(22):1253-8. PubMed ID: 7421962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-GM1 IgG antibodies induce leukocyte effector functions via Fcgamma receptors.
    van Sorge NM; van den Berg LH; Geleijns K; van Strijp JA; Jacobs BC; van Doorn PA; Wokke JH; van de Winkel JG; Leusen JH; van der Pol WL
    Ann Neurol; 2003 May; 53(5):570-9. PubMed ID: 12730990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive effect of IgA soluble immune complexes on neutrophil chemotaxis.
    Ito S; Mikawa H; Shinomiya K; Yoshida T
    Clin Exp Immunol; 1979 Sep; 37(3):436-40. PubMed ID: 116785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in normal polymorphonuclear leucocyte motility after ingestion of IgG aggregates.
    Goddard DH; Kirk AP; Brown KA; McCarthy D; Johnson GD; Holborow EJ
    Ann Rheum Dis; 1984 Apr; 43(2):146-50. PubMed ID: 6712289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific effects on human neutrophils of antibodies to a membrane protein constituent of neutrophil receptors for chemotactic formyl-methionyl peptides.
    Goetzl EJ; Foster DW; Goldman DW
    Immunology; 1982 Feb; 45(2):249-56. PubMed ID: 6277773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of measurements of allergen-specific IgG antibodies as an in vitro monitor of specific immunotherapy.
    Ali M
    Ann Allergy; 1985 Mar; 54(3):258-9. PubMed ID: 2579605
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-idiotype antibodies to anti-myeloperoxidase autoantibodies in patients with systemic vasculitis.
    Jayne DR; Esnault VL; Lockwood CM
    J Autoimmun; 1993 Apr; 6(2):221-6. PubMed ID: 8388692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-idiotype as antibody against the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA; Becker EL
    J Immunol; 1982 Feb; 128(2):963-8. PubMed ID: 7054297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro binding to granulocytes of two anti-NCA 95 monoclonal antibodies: Mab1 (ORIS) and Mabgc (Mallinckrodt).
    Collet B; Moisan A; Maros S; Toujas L; Herry JY
    Prog Clin Biol Res; 1990; 355():293-8. PubMed ID: 2281109
    [No Abstract]   [Full Text] [Related]  

  • 12. IgM-anti-IgG antibody as cause of positive B-cell crossmatches.
    Terness P; Berteli AJ; Steinitz M; Mytillineos J; Opelz G
    Transplant Proc; 1990 Aug; 22(4):1885-6. PubMed ID: 2389472
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of allergen-specific IgE and IgG responses by anti-idiotypic antibodies.
    Nagpal S; Shanthi KN; Kori R; Schroder H; Metcalfe DD; Subba Rao PV
    J Immunol; 1989 May; 142(10):3411-5. PubMed ID: 2785554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rheumatoid factor and its related anti-IgG antibodies: the present state and perspective].
    Ota T
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Aug; 25(4):319-29. PubMed ID: 16583739
    [No Abstract]   [Full Text] [Related]  

  • 15. Idiotype switching of CD4-specific monoclonal antibodies can prolong the therapeutic effectiveness in spite of host anti-mouse IgG antibodies.
    Jonker M; Den Brok JH
    Eur J Immunol; 1987 Nov; 17(11):1547-53. PubMed ID: 3500064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abolition of resistance to Klebsiella pneumoniae by anti-polymorphonuclear leucocyte IgG.
    Bullen JJ; Leach PA; Lange L
    Immunology; 1980 Jan; 39(1):47-52. PubMed ID: 6991395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effects of IgA on human polymorphonuclear leukocytes.
    Sibille Y; Delacroix DL; Merrill WW; Chatelain B; Vaerman JP
    Adv Exp Med Biol; 1987; 216A():573-9. PubMed ID: 3687543
    [No Abstract]   [Full Text] [Related]  

  • 18. Subclass distribution of IgG anti-IgE autoantibodies.
    Wilson PB; Fairfield JE
    Monogr Allergy; 1989; 26():176-83. PubMed ID: 2788812
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of human IgG on locomotion of human neutrophils related to IgG binding of a hydrophobic probe.
    Wilkinson PC
    Immunology; 1980 Oct; 41(2):457-66. PubMed ID: 7439936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1-inhibitor deficiency with antiidiotypic antibody.
    Scovern H
    N Engl J Med; 1985 Jun; 312(25):1643. PubMed ID: 3873613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.